RXO Stockholders Approve 7 Million Share Increase for Incentive Plan
RXO sits 90% above its 52-week low of $10.425.
Summary
RXO stockholders approved an increase of 7 million shares for the company's incentive compensation plan, representing a potential dilution of nearly 5% for existing shareholders.
Key Events · Corporate Governance and Compliance · RXO
-
Incentive Plan Share Increase Approved
Stockholders approved an amendment to the 2022 Omnibus Incentive Compensation Plan, authorizing an additional 7 million shares for issuance. If all authorized shares were issued, dilution would be approximately 4.68%.
-
Directors Elected
All eight nominated directors, including Drew Wilkerson and Thomas Szlosek, were elected to the board for a term expiring in 2027.
-
Auditor Ratified
Deloitte & Touche LLP was ratified as the independent registered public accounting firm for fiscal year 2026.
-
Executive Compensation Approved
Stockholders provided advisory approval for the compensation of named executive officers.
Analysis · RXO · Energy & Transportation
RXO's stockholders approved an amendment to the 2022 Omnibus Incentive Compensation Plan, authorizing the issuance of an additional 7 million shares for employee incentives. This represents a potential dilution of approximately 4.68% for existing shareholders if all these shares are issued. While common for compensation, the magnitude of potential dilution is notable.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RXO was trading at $19.81 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $3.3B. The 52-week trading range was $10.43 to $23.37. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.